CTLA 4 News and Research

RSS
Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Tumor-infiltrating lymphocytes therapy treats cancers at a large scale

Tumor-infiltrating lymphocytes therapy treats cancers at a large scale

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Cytokine-based cancer immunotherapy: Current progress and future prospects

Cytokine-based cancer immunotherapy: Current progress and future prospects

Study illustrates how the use of whole exome sequencing can better predict treatment response

Study illustrates how the use of whole exome sequencing can better predict treatment response

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

How specific comorbidities impact severity of COVID-19

How specific comorbidities impact severity of COVID-19

Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

Discovery provides critical clues to why many immunotherapies trigger dangerous side effects

Discovery provides critical clues to why many immunotherapies trigger dangerous side effects

New study pinpoints how immune checkpoint protein LAG3 modulates T cell activity

New study pinpoints how immune checkpoint protein LAG3 modulates T cell activity

Study finds better immunotherapy response in lung cancer patients with genetic variant linked to autoimmune disease

Study finds better immunotherapy response in lung cancer patients with genetic variant linked to autoimmune disease

Combination immunotherapy reverses resistance to PD-1 inhibitors in patients with advanced melanoma

Combination immunotherapy reverses resistance to PD-1 inhibitors in patients with advanced melanoma

FDA approves new treatment for patients with metastatic melanoma based on Johns Hopkins research

FDA approves new treatment for patients with metastatic melanoma based on Johns Hopkins research

Study explores signature gut microbiome connection with immune checkpoint inhibitor response in advanced melanomas

Study explores signature gut microbiome connection with immune checkpoint inhibitor response in advanced melanomas

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

Study opens a window for new therapeutic approaches to ovarian cancer

Study opens a window for new therapeutic approaches to ovarian cancer

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

UAB researchers show how to identify non-responding tumors and improve immunotherapy response